Bayer Expects Big Gains In APAC With Late-stage Pipeline And Zydus Cadila Joint Venture
Bayer expects half of its 43 clinical trials to be ready for the market in the next few years in Southeast Asia.
Bayer expects half of its 43 clinical trials to be ready for the market in the next few years in Southeast Asia.